Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using CT-Derived Body Composition

Clicks: 5
ID: 318061
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #508 of 550 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 550 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
OBJECTIVE: To determine whether CT-derived body composition and kidney function better predict cefazolin concentrations at the surgical site than body weight alone in patients with obesity undergoing colorectal surgery. BACKGROUND: Current cefazolin prophylaxis guidelines recommend dose escalation from 2 g to 3 g in patients weighing ≥120 kg. However, body weight inconsistently reflects antibiotic distribution at the surgical site. METHODS: We conducted a prospective study of adults with obesity undergoing elective colorectal surgery who received cefazolin prophylaxis and had preoperative CT imaging. Cefazolin concentrations were measured in plasma, subcutaneous adipose tissue, and colorectal tissue during surgery. CT-derived body composition metrics were quantified using analytic morphomics. Modeling and simulations were used to identify predictors of target attainment in subcutaneous tissue. Agreement between revised physiologic dosing criteria and current weight-based guidance was assessed in both a derivation cohort and an independent external cohort. RESULTS: Among 153 patients, 58 were included in model development and 95 in prospective evaluation. Weight and BMI did not improve model performance. Subcutaneous fat area (SFA) predicted tissue exposure, while creatinine clearance (CLcr) predicted elimination. Current weight-based dosing achieved 78%-84% target attainment. A revised framework of SFA ≥500 cm2 or ≥300 cm2 with CLcr ≥90 mL/min identified an additional 10%-14% of patients for dose adjustment, improving identification of underdosing-related SSI risk without unnecessary antibiotic use. CONCLUSIONS: Cefazolin exposure is better explained by local adiposity and kidney function than by the current ≥120 kg weight-based dosing threshold.
Reference Key
openalex_W7165468600 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Manjunath P. Pai, Aleksas Matvekas, J. A. Sullivan, Shuhan Liu, L Y Wang, Brian A. Derstine, Brian Ross, Hari Prabhath Tummala, Scott Regenbogen, J F Byrn, Grace L. Su, MD PhD Stewart Wang
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag383
URL
https://doi.org/10.1093/cid/ciag383
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.